Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Sector Gamma AS

Sector Gamma AS cut its holdings in Cardinal Health, Inc. (NYSE:CAH) by 24.8% during the 4th quarter, Holdings Channel reports. The firm owned 88,000 shares of the company’s stock after selling 29,098 shares during the period. Cardinal Health comprises approximately 3.6% of Sector Gamma AS’s investment portfolio, making the stock its 11th biggest holding. Sector Gamma AS’s holdings in Cardinal Health were worth $10,408,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of the business. Wayfinding Financial LLC purchased a new stake in Cardinal Health in the 4th quarter worth approximately $236,000. Lee Danner & Bass Inc. acquired a new position in shares of Cardinal Health in the 4th quarter valued at $35,000. Whittier Trust Co. boosted its holdings in shares of Cardinal Health by 30.7% in the 4th quarter. Whittier Trust Co. now owns 1,729 shares of the company’s stock valued at $204,000 after purchasing an additional 406 shares during the last quarter. Magnetar Financial LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at $10,494,000. Finally, Fiduciary Group LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at $210,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Up 0.7 %

Shares of NYSE:CAH opened at $133.02 on Friday. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $133.77. The firm has a 50-day simple moving average of $127.15 and a 200 day simple moving average of $119.87. The company has a market cap of $32.13 billion, a PE ratio of 24.82, a P/E/G ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s payout ratio is 37.69%.

Analysts Set New Price Targets

A number of brokerages have weighed in on CAH. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a report on Tuesday, January 7th. Wells Fargo & Company lifted their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Argus set a $148.00 price objective on shares of Cardinal Health in a report on Tuesday, February 4th. JPMorgan Chase & Co. boosted their price objective on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Finally, Mizuho began coverage on shares of Cardinal Health in a report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price objective on the stock. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.